|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of Sales | |||||
| Gross profit | |||||
| Other operating income | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Operating loss | |||||
| Interest income | |||||
| Interest expense | |||||
| Foreign currency exchange gain/(loss), net | |||||
| Revaluation gain/(loss) from derivative financial instruments | |||||
| Transaction costs | |||||
| Finance income | |||||
| Finance expense | |||||
| Share of loss of an associate | |||||
| Loss before tax | |||||
| Income tax gain | |||||
| Net loss from continuing operations | |||||
| Profit/(loss) after tax from discontinued operations | |||||
| Net loss attributable to owners of the Company | |||||
| Remeasurements of defined benefit liability, net of taxes of $0 | |||||
| Foreign currency translation differences, net of taxes of CHF 0 | |||||
| Items that are or may be reclassified to profit or loss | |||||
| Foreign currency translation differences, net of taxes of $0 | |||||
| Share of other comprehensive income of an associate | |||||
| Other comprehensive income/(loss), net of taxes of $0 | |||||
| Total comprehensive loss attributable to owners of the Company | |||||
| Loss per share | |||||
| Basic loss per share (in Dollars per share) | |||||
| Diluted loss per share (in Dollars per share) | |||||
| Basic loss per share from continuing operations (in Dollars per share) | |||||
| Diluted loss per share from continuing operations (in Dollars per share) | |||||
Loading...
